Description

This quarterly Intelligence provides over 10 charts and graphs providing clear graphical data highlighting current regulatory trends for pharmaceuticals reported on an individual citation level. An executive summary provides a synopsis of all data presented within the Intelligence and significant changes in regulatory trends. Current Good Manufacturing Practices, Packaging and Clinical categories are successively drilled down to identify the top 8 citations for pharmaceuticals. Significant pharmaceutical regulatory subparts are identified through charts and graphs. Active links to all Warning Letters for the 2 yr time period reported are provided as well as links to FDA regulations for easy reference eliminating FDA website navigation. Insider Intelligences are used not only for regulatory trends but also as training tools using all links provided